As I wrote in my premarket watchlist for TIMalert subscribers today, ARNA was a potential short because it’s a hype-filled piece of crap biotech (yup, I said it, look at their fundamentals, $2 mil in quarterly revenue, $55mil in quarterly losses!?!?!?…horrendous, only thing that’s saved them this long is that they aren’t a leverage-loving financial)…
I watched the stock all day, narrowly missing my morning short when it took out support at $6.25–not that it matters for my premium subscribers as I discuss in my PennyStocking Part Deux DVD, morning panics are difficult, if not impossible, to send out alerts on because they happen too fast–that’s why I greatly prefer another pattern I cover over and over (see this full independent review HERE I just found last night), the afternoon fade…
…and once ARNA did its 15%+ morning drop, go sideways for several hours right around $6–not surprisingly, this was support from a few days ago…which it held that time before short squeezing to $7+–so I figured if it took out that key support, second time’s the charm…long story short I shorted 2000 at $5.98 late this afternoon and was very pleased by the obvious chart top that has now developed:
After all, the reason for this carcass’ surge was the CEO running his big fat sugarcoated/cheerleading mouth on CNBC about how great their pill for fat people was and how confident he is that it’ll pass late stage trials, (the reporter asked him why he’s so confident, he pointed to successful phase 2 trials aka every phase 3 drug trial has passed phase 2, it DOES NOT MEAN THEY WILL PASS PHASE 3…or else every drug passing phase 2 would somehow skip past phase 3 to acceptance), the results of which will be announced in late March….that got all the shorts scared and lots of dumb CNBC viewers down 40-50% got to thinking this is their last shot at being middle-class again.
On top of that, the last time I shorted it at $6.15, Agora Financial came out and promoted the hell out of this, sucking in their dumb-as-Vick subscribers into believing this was the stock that could make them rich…FYI Agora owns 500+ internet domains, they have subscribers coming out their ears…add together a potentially great-but-longshot (as evidenced by the horrific long-term stock chart that no amount of CNBC/Agora/CEO cheerleading can hide)story + Agora saps and CNBC chumps and you got a powder keg
Well, the hype can only last for so long and today’s UBS downgrade–who woulda thought a friggin ANALyst would be the reasonable one for once–really reminded people as to the potential risk of this carcass:
“Although we remain positive on the expected outcome of the Bloom and Blossom (lorcaserin) trials, until final data is available the potential for negative efficacy and safety results cannot be eliminated,” he said in a note to investors.
Also, the Food and Drug Administration has been taking a more conservative approach to approving new treatments, Elliott added. Results from the Bloom study are expected in March.
Considering the beautiful price action today, the overall chart pattern and most importantly, the axis-of-evil-TV-spam-CEO-typical-cheerleading hype that caused this runup, I’d like to cover tomorrow or the next day between $5 and $5.50 for profits of $2,000 to $1,000
You gotta love the manipulation game and recognizing when a stock has been manipulated higher, not illegally, just by the natural self-interests of the parties involved. That’s Wall Street.
Tags: Breakdowns, Manipulation, Patterns To Short




















